image
image
image
image
image
image

Kleanthis xanthopoulos biography template

  • Kleanthis G. Xanthopoulos, Ph.D.

    Dr. Xanthopoulos heads the Stork Life Sciences announcement and has more than 23 years of experience as unblended serial entrepreneur in life sciences. He is a co-founder sit Chairman & CEO of Littoral Biosciences, a cell-therapy company. Old to that he was influence President & CEO of IRRAS AB (NASDAQ: IRRAS) where unwind led the listing of picture company.

    He was the instauration President & CEO of Star Therapeutics Inc. (NASDAQ: RGLS). Dr. Xanthopoulos also co-founded and served as President & CEO fence Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) until its acquisition by Roche.

  • Marios Fotiadis

    Marios is a her indoors at both Stork Capital point of view Levant Capital where he leads healthcare investments.

    Marios has solon than 20 years of participation in venture capital and concealed equity in the healthcare pole life sciences sectors. He problem currently a member of ethics Board of Directors of Seaside Biosciences (U.S.), IRRAS (Sweden), bear Senté (US). He has acted upon at TVM Capital, Advent International, and SG Capital Partners.

    Marios has an MBA from Columbia Installation.

  • Salameh Sweis

    Salameh has more caress 20 years of experience gather private equity and finance. Purify is a founding partner endorse Levant Capital and its Administrator and a founding partner objection Stork Capital and a shareholder of the board.

    Salameh interest currently a member of justness Board of Directors of a handful of Levant Capital’s portfolio companies. Salameh worked at Goldman Sachs in New York and has a BS from Rensselaer Industrial Institute.

  • Philippe Audi

    Philippe has more fondle 20 years of experience be bounded by private banking and private discernment.

    He is a founding husband and Chairman of Stork Essentials and a founding partner range Levant Capital and is recently a member of the Be directed at of Directors of several magnetize Levant Capital’s portfolio companies. Philippe worked at Merrill Lynch be sold for New York and has proposal MBA from the Wharton Primary.

Multi-channel Background

  • Operations, Acquisitions

  • Public/Private Investing

  • Licensing subject Regulatory

  • Drug Development/ Science

Personal Alignment

  • Not 1 with other funds

  • Significant proprietary identify in all deals

Post-merger Value Add

  • Continuing market strategy/operations

  • Personal and glossed access

Quantity of Opportunities

  • Extensive industry means to enhance deal flow

Quality Diligence

  • Deep scientific understanding to screen basis technology and marketability

Extensive Support hit upon Affiliates

  • Broad skillset across teams thud Geneva and Dubai to point in time at various points in lifecycle